Meeting Banner
Abstract #1161

Susceptibility contrast-MRI predicts response to the vascular endothelial growth factor receptor inhibitor cediranib in the Th-MYCN model of neuroblastoma

Konstantinos Zormpas-Petridis1, Matthew D. Blackledge1, Louis Chesler2, Yinyin Yuan3, Simon P. Robinson1, and Yann Jamin1

1Division of Radiotherapy and Imaging, Institute of Cancer Research, London, United Kingdom, 2Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom, 3Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom

In this study we demonstrate that fractional blood volume, measured by susceptibility contrast-MRI, predicts response to the vascular endothelial growth factor receptor inhibitor cediranib in the Th-MYCN genetically-engineered mouse model of neuroblastoma.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords